Top compounds associated with response to C10orf113


Feature Type Standardized
Nominal ANOVA
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.087 0.02
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.079 0.02
mRNA lovastatin CTRPv2 pan-cancer AAC -0.084 0.03
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.03
mRNA Irinotecan gCSI pan-cancer AAC -0.11 0.03
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC -0.089 0.03
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.076 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
Download CSV